Cite
HARVARD Citation
Hernando Cubero, J. et al. (n.d.). 1329PEfficacy and safety of vandetanib for patients with advanced and progressive medullary thyroid cancer (MTC) as systemic treatment beyond first-line therapy. Annals of oncology. p. . [Online].